Artificial Insemination Market –Regional Insights
On the basis of the region, theglobal ArtificialInsemination Market is segmented into North America, Latin America, Europe,Asia Pacific, Middle East, and Africa. North America market holds the dominantposition in the global artificial insemination market, owing to technologicaladvancements and favorable rules and regulations in the region. For instance,according to 2018 National Conference of State Legislature report, 14 stateshave laws mandating that employers offer insurance for fertility treatment.Hawaii, Arkansas, Texas, and Maryland mandate coverage for in vitrofertilization only, excluding inseminations.
Furthermore, Asia Pacificartificial insemination market is projected to witness significant growth owingto increasing prevalence of infertility among the populace and less stringentregulations. For instance, according to the United Nation Department of Economicand Social Affairs 2015 report shows a fertility rate decline from 1.3 to 1.4children per woman.
Artificial insemination is amedical process for the purpose of achieving pregnancy through intentionalintroduction of sperm in a female’s uterus by means other than sexual intercourse.Artificial insemination is a fertility treatment process for humans, and is ausual practice for animal breeding. Recipients of artificial inseminationinclude single mothers and infertile couples. Intrauterine Insemination (IUI)is the most widely operated method of artificial insemination. Increaseprevalence of infertility is a key factor contributing to growth of artificialinsemination market.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1793
For instance, according toresearch published in 2012 PLOS Medicine, around 48.5 million couples worldwidewere unable to conceive a child in 2010. Market players often offer home-usekits, including ovulation kits, pregnancy detection kits, and inseminationdevices.
Artificial Insemination MarketDynamics
Major pharmaceutical companiesare vigorously developing products that are in clinical and preclinical trialsand launching new insemination kits that have demonstrated potential benefits,which in turn is propelling the artificial insemination market growth. Forinstance, 2015 clinical trial study of Stork OTC kit showed effectiveness atdelivering higher concentration of sperm to the cervix than naturalintercourse. The Stork OTC delivered 3.23x higher value of sperm concentrationto around 85% of the subjects in the study, whereas the remaining 15% showed nochange in sperm concentration at the cervix. The Stork OTC received FDAover-the-counter approval in July 2014. The kit helps collect, insert, andtransport sperms directly at the opening of the cervix for prolong duration,providing sperms the opportunity to enter into the uterus. The Stork OTCprovides a safe and simple way for users to avoid unfavorable vaginal environment,to deliver the sperm.
Moreover, according to theNational Women’s Health Resource Center, infertility impacts over 20 millionwomen. According to 2017 United Nations World Population prospects report,total fertility is expected to decrease from 2.43 to 2.39 (children per woman)between 2020 and 2030. Increasing incidence of infertility among the globalpopulace is majorly boosting growth of the artificial insemination market.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/artificial-insemination-market-1793
However, stringent regulationsbeing implemented by most countries regarding who is applicable to receivefertility treatments, is hindering growth of the artificial insemination marketsize. For instance, Italy and France forbid lesbian couples and single womenfrom using artificial insemination. Italy and Austria are among those banningall sperm and egg donations for IVF. Norway and Germany ban egg donations, however,allow sperm donations.
Artificial Insemination Market –Competitive Landscape
Key players operating in theglobal artificial insemination market include Pride Angel, Irvine Scientific,Hi-Tech Solutions, Rinovum Women’s Health, LLC, TenderNeeds Fertility,Conceivex, Inc., Labotech GmbH, Hamilton Throne Ltd., Biogenics Inc., NikonInstruments Inc., Zander scientific Inc., and Surelife Pte Ltd. Key players areadoption growth strategies such as collaborations, acquisition, and new productlaunches to maintain a dominant position in the market. For instance, in 2016,Worthington Industries, in collaboration with Intellectual Ventures, launchedthe innovative AIS 3 and AIS 1.5 artificial insemination shield refrigeratorsequipped with the advanced artificial insemination shield canisters for holdingsamples.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1793
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
